ROSEMARY MAZANET
CIK 1276892 · Chief Scientific Officer · last filed 2025-04-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
37
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | — | $0.53 | — | $0 | 6 | 2024-06-24 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Chief Medical Officer | — | — | — | $0 | 2 | 2013-01-31 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Director | 22,781 | — | — | $0 | 12 | 2009-05-11 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-30 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-05 | — | Mixed | +67,825 | -$21.0K | |
| 2023-04-13 | — | Mixed | +104,984 | -$37.4K | |
| 2022-12-28 | — | Mixed | +28,056 | -$11.5K | |
| 2022-10-21 | — | Mixed | +14,887 | -$11.4K | |
| 2022-06-17 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-03 | — | Mixed | +80,404 | -$147.4K | |
| 2022-04-14 | — | Grant (A) | — | $0 | |
| 2021-05-27 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-16 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.